Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Attention Job Seekers: The Most In-Demand Jobs To Watch For In 2021 -
Mandhana slips 2 places to 6th among batters; Goswami still at 5th among bowlers in ODI rankings -
Om Raut Says He Isn't An Accidental Filmmaker; Reveals He Had Attended The Premiere Of Jurassic Park -
Roohi Promotions: Janhvi Kapoor Flaunts Bold Makeup Look With Kohl Rimmed Eyes And Nude Glossy Lips -
Saral Suraksha Bhima Policy: 5 Things To Know About The Standard Insurance Cover -
10 Best Family-Friendly Destinations To Visit In India In March -
Xiaomi Mi 10T Price Permanently Axed By Rs. 3,000 In India: Worth Buying? -
New Bajaj Platina 100 ES Electric Start Launched In India: Prices Start At Rs 53,920
Covid-19: Beginning 2021, India to produce 100 million doses of Russia’s Sputnik V vaccine
New Delhi, Nov 27: Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth fund said in a statement.
The parties intend to start the production of Sputnik V in the beginning of 2021, it added.
Oxford Astra Zeneca's vaccine error | What happens to India trials? | Oneindia News
Currently Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries. Phase II-III trials are taking place in India, RDIF said.
